Left Atrial Geometry Improves Risk Prediction of Thromboembolic Events in Patients With Atrial Fibrillation

• Published in: Journal of cardiovascular electrophysiology 2016-07, Vol.27 (7), p.804-810
• Main Authors: BISBAL, FELIPE, GÓMEZ-PULIDO, FEDERICO, CABANAS-GRANDÍO, PILAR, AKOUM, NAZEM, CALVO, MIREIA, ANDREU, DAVID, PRAT-GONZÁLEZ, SUSANNA, PEREA, ROSARIO J., VILLUENDAS, ROGER, BERRUEZO, ANTONIO, SITGES, MARTA, BAYÉS-GENÍS, ANTONI, BRUGADA, JOSEP, MARROUCHE, NASSIR F., MONT, LLUÍS
• Format: Article
• Language: English
• Subjects: Aged; Area Under Curve; Atrial Appendage - diagnostic imaging; Atrial Appendage - physiopathology; atrial fibrillation; Atrial Fibrillation - complications; Atrial Fibrillation - diagnostic imaging; Atrial Fibrillation - physiopathology; Atrial Function, Left; Atrial Remodeling; Blood Coagulation; catheter ablation; Chi-Square Distribution; Coronary Angiography - methods; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; left atrial remodeling; Logistic Models; Magnetic Resonance Angiography; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Spain; sphericity; stroke; Stroke - diagnosis; Stroke - etiology; thromboembolism; Thromboembolism - blood; Thromboembolism - diagnosis; Thromboembolism - etiology; Utah
• ISSN: 1045-3873; 1540-8167
• DOI: 10.1111/jce.12978

LA Sphericity and Stroke Prediction Background Left atrial (LA) sphericity (LASP) is a new remodeling parameter based on LA shape analysis, with independent predictive value for recurrence after atrial fibrillation (AF) ablation. Objectives To evaluate the association between LASP and thromboembolic events (TE) in patients with AF. Methods Twenty‐nine AF patients and prior TE and 29 age‐ and gender‐matched controls were included. LASP was calculated using a 3D‐LA reconstruction. The LA appendage (LAA) volume and morphology were assessed. ROC curve analysis was performed for LASP, LA volume, LAA volume, and CHAD/CHA2D–VASc scores (Stroke2—the grouping variable—was excluded). Results Mean age of the study population was 61 ± 11 years (79.3% males, 53.4% hypertension, 8.6% diabetes). Patients with prior TE had higher LASP than those without (82.5 ± 3.3% vs. 80.2 ± 3.1%, P = 0.008); there were no differences in CHAD or CHA2D–VASc scores, LA volume, LAA volume, or LAA morphology. The C‐statistic was higher for LASP (0.71) than for other tested variables (CHAD score = 0.58, CHA2D–VASc score = 0.59, LA volume = 0.50, LAA volume = 0.46; P < 0.01 for all vs. LASP). The best cutoff value for LASP was 83.6% (sensitivity 0.52, specificity 0.90). Logistic regression analysis showed predictive value for LASP (OR 1.26 per each 1% increase [1.85–52.20], P = 0.013), but not for clinical risk scores. The addition of LASP to the CHAD and CHA2D–VASc scores increased the predictive value over the risk scores alone (P = 0.004), and reclassified 45.5% of patients with CHAD = 0 (no anticoagulation indicated) to moderate‐risk (anticoagulation indicated). Conclusion LA sphericity is associated with prior TE in AF patients and improves the performance of the CHAD and CHA2D–VASc scores alone.